首页> 美国卫生研究院文献>other >Use of a Small Peptide Fragment as an Inhibitor of Insulin Fibrillation Process: A Study by High and Low Resolution Spectroscopy
【2h】

Use of a Small Peptide Fragment as an Inhibitor of Insulin Fibrillation Process: A Study by High and Low Resolution Spectroscopy

机译:使用小肽片段作为胰岛素原纤化过程的抑制剂:高分辨和低分辨光谱学研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A non-toxic, nine residue peptide, NIVNVSLVK is shown to interfere with insulin fibrillation by various biophysical methods. Insulin undergoes conformational changes under certain stress conditions leading to amyloid fibrils. Fibrillation of insulin poses a problem in its long-term storage, reducing its efficacy in treating type II diabetes. The dissociation of insulin oligomer to monomer is the key step for the onset of fibrillation. The time course of insulin fibrillation at 62°C using Thioflavin T fluorescence shows an increase in the lag time from 120 min without peptide to 236 min with peptide. Transmission electron micrographs show branched insulin fibrils in its absence and less inter-fibril association in its presence. Upon incubation at 62°C and pH 2.6, insulin lost some α-helical structure as seen by Fourier transformed infra-red spectroscopy (FT-IR), but if the peptide is added, secondary structure is almost fully maintained for 3 h, though lost partially at 4 h. FT-IR spectroscopy also shows that insulin forms the cross beta structure indicative of fibrils beyond 2 h, but in the presence of the peptide, α-helix retention is seen till 4 h. Both size exclusion chromatography and dynamic light scattering show that insulin primarily exists as trimer, whose conversion to a monomer is resisted by the peptide. Saturation transfer difference nuclear magnetic resonance confirms that the hydrophobic residues in the peptide are in close contact with an insulin hydrophobic groove. Molecular dynamics simulations in conjunction with principal component analyses reveal how the peptide interrupts insulin fibrillation. In vitro hemolytic activity of the peptide showed insignificant cytotoxicity against HT1080 cells. The insulin aggregation is probed due to the inter play of two key residues, PheB24 and TyrB26 monitored from molecular dynamics simulations studies. Further new peptide based leads may be developed from this nine residue peptide.
机译:一种无毒的,具有九个残基的肽NIVNVSLVK被证明可通过多种生物物理方法干扰胰岛素原纤化。胰岛素在某些应激条件下会发生构象变化,从而导致淀粉样蛋白原纤维。胰岛素的原纤化在其长期储存方面存在问题,降低了其治疗II型糖尿病的功效。胰岛素低聚物解离成单体是发生原纤化的关键步骤。使用硫黄素T荧光在62°C进行胰岛素原纤化的时间过程显示,滞后时间从无肽的120分钟增加到有肽的236分钟。透射电子显微照片显示在不存在时分支胰岛素原纤维和在其存在时原纤维间缔合较少。在傅里叶变换红外光谱(FT-IR)中观察到,在62°C和pH 2.6下孵育后,胰岛素失去了一些α螺旋结构,但是如果添加了肽,则二级结构几乎可以完全维持3小时,尽管4小时后部分丢失。 FT-IR光谱还显示,胰岛素在超过2小时后形成交叉β结构,表明原纤维,但是在存在肽的情况下,直到4 h都可以看到α-螺旋的保留。尺寸排阻色谱法和动态光散射法均表明,胰岛素主要以三聚体形式存在,其向单体的转化受到肽的抵抗。饱和转移差异核磁共振证实了肽中的疏水残基与胰岛素疏水沟紧密接触。结合主成分分析的分子动力学模拟揭示了该肽如何打断胰岛素原纤化。该肽的体外溶血活性对HT1080细胞显示出微不足道的细胞毒性。由于分子动力学模拟研究监测了两个关键残基Phe B24 和Tyr B26 的相互作用,因此发现了胰岛素聚集。可以从这九个残基的肽中开发出新的基于肽的前导物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号